High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior

Journal of Psychiatric Research
Teng-Yun WuYun-Xia Wang

Abstract

Depression disorder is a common mental illness, of which the pathogenesis is not well understood. Studies suggest that immunity imbalance and up-regulation of pro-inflammatory cytokines may be associated with the pathogenesis of depression. High-mobility group box 1 protein (HMGB1) has gained much attention as an important player in innate immune responses and an modulating factor in several inflammatory diseases. Here we sought to explore the role of HMGB1 in the development of depression. Depression model was established with low dose of lipopolysaccharide (LPS) administration. Depressive behavior was reflected with increased immobility time in tail suspension test. Accompanying with depressive-like behavior, translocation of HMGB1 from nuclei to cytoplasm was observed by immunofluorescence assays. Meanwhile, no significant necrosis was observed evaluated by hematoxylin-eosin staining. These data indicated that HMGB1 was released actively in the central nervous system. In addition, treating the mice with human recombinant HMGB1 (rHMGB1) could induce the development of depressive-like behavior. Blockage of HMGB1 with GZA abrogated the depressive-like behavior induced by LPS or rHMGB1. These results implicated that HMGB1 was in...Continue Reading

References

Jul 1, 1975·Psychosomatic Medicine·R Ader, N Cohen
Jan 1, 1992·Trends in Pharmacological Sciences·S KentR Dantzer
Nov 1, 1988·Acta Psychiatrica Scandinavica·A NiiranenK Cantell
Jul 1, 1994·Trends in Pharmacological Sciences·P Blier, C de Montigny
Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Jul 10, 1999·Science·H WangK J Tracey
Aug 22, 2000·The Journal of Experimental Medicine·U AnderssonK J Tracey
Oct 3, 2003·The Journal of Dermatological Treatment·M SaeediM-R Ghoreishi
Mar 1, 2005·Journal of Leukocyte Biology·Huan YangKevin J Tracey
Apr 2, 2005·Nature Reviews. Immunology·Michael T Lotze, Kevin J Tracey
May 12, 2005·Neuroscience and Biobehavioral Reviews·Adrian J DunnRenaud de Beaurepaire
Jun 29, 2005·Pharmacology, Biochemistry, and Behavior·Adrian J Dunn, Artur H Swiergiel
Aug 6, 2005·Journal of Leukocyte Biology·Weiwen JiangDavid S Pisetsky
Aug 10, 2005·Behavioural Brain Research·Michel BourinDenis Joseph Paul David
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Mar 4, 2006·Cytokine & Growth Factor Reviews·Luis Ulloa, Davorka Messmer
Apr 25, 2006·Biological Psychiatry·Ronald S Duman, Lisa M Monteggia
Sep 14, 2006·Current Medical Research and Opinion·Márcio MachadoThomas R Einarson
Apr 28, 2007·Chemistry & Biology·Jean-Philippe Girard
Apr 28, 2007·Chemistry & Biology·Luca MollicaMarco E Bianchi
Mar 12, 2008·Current Molecular Medicine·Heikki Rauvala, Ari Rouhiainen
Jun 25, 2008·Circulation·Martin AndrassyAngelika Bierhaus
Dec 10, 2008·The Journal of Experimental Medicine·Vilma UrbonaviciuteReinhard E Voll
Nov 3, 2010·Psychoneuroendocrinology·Robert DantzerKeith W Kelley
Jan 12, 2011·Annual Review of Immunology·Ulf Andersson, Kevin J Tracey
Feb 22, 2011·Pharmacology & Therapeutics·Lucile Capuron, Andrew H Miller
Jan 19, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Il-Doo KimJa-Kyeong Lee
Mar 1, 2012·The Journal of Experimental Medicine·Milena SchiraldiMariagrazia Uguccioni
Aug 24, 2012·Annals of Neurology·Yu OkumaMasahiro Nishibori
May 2, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karsten RuscherTadeusz Wieloch
Nov 28, 2013·CNS Neuroscience & Therapeutics·Yi ZhangChun-Lei Jiang
Jul 11, 2014·Molecular Aspects of Medicine·Rui KangDaolin Tang

❮ Previous
Next ❯

Citations

Jan 23, 2016·Brain, Behavior, and Immunity·Andrea WieckMoisés Evandro Bauer
Jan 7, 2016·Frontiers in Cellular Neuroscience·Dora Brites, Adelaide Fernandes
Jun 10, 2016·Nature Reviews. Neuroscience·Eric S WohlebRonald S Duman
Sep 21, 2016·Brain, Behavior, and Immunity·Yong-Jie LianYun-Xia Wang
Sep 29, 2019·Stress : the International Journal on the Biology of Stress·Jiah Pearson-LearySeema Bhatnagar
Apr 28, 2017·Current Opinion in Anaesthesiology·Jeffery A Katz, Glenn S Murphy
Sep 4, 2018·Frontiers in Neuroscience·Eva M Medina-RodriguezEléonore Beurel
Oct 6, 2020·Pharmacological Reports : PR·Tarapati RanaSimona Bungau
Dec 3, 2020·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Yue LuXiaoying Bi
Jan 8, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Felipe Dal-PizzolTarek Sharshar
Jun 17, 2019·Journal of Neuroimmunology·Cynthia Marie-ClaireFrank Bellivier
Nov 21, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Wanying ShanJie Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.